Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients.

Bharati SM, Singh N.

J Pharmacol Pharmacother. 2016 Apr-Jun;7(2):80-6. doi: 10.4103/0976-500X.184771.

2.

Antihypertensive Drug Use and New-Onset Diabetes in Female Patients with Coronary Artery Disease: A Population-based Longitudinal Cohort Study.

Liou YS, Chen HY, Tien L, Gu YS, Jong GP.

Medicine (Baltimore). 2015 Sep;94(36):e1495. doi: 10.1097/MD.0000000000001495. Erratum in: Medicine (Baltimore). 2016 Feb;95(8):e8000.

3.

Blood pressure and mortality: using offspring blood pressure as an instrument for own blood pressure in the HUNT study.

Wade KH, Carslake D, Nilsen TI, Timpson NJ, Davey Smith G, Romundstad P.

Sci Rep. 2015 Jul 22;5:12399. doi: 10.1038/srep12399.

4.

Cost-utility of angiotensin-converting enzyme inhibitor-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity.

Chowdhury EK, Ademi Z, Moss JR, Wing LM, Reid CM; Second Australian National Blood Pressure Study Management Committee..

Medicine (Baltimore). 2015 Mar;94(9):e590. doi: 10.1097/MD.0000000000000590.

6.

Systolic hypertension: an increasing clinical challenge in Asia.

Park JB, Kario K, Wang JG.

Hypertens Res. 2015 Apr;38(4):227-36. doi: 10.1038/hr.2014.169. Epub 2014 Dec 11. Review.

7.

Antihypertensive drugs and glucose metabolism.

Rizos CV, Elisaf MS.

World J Cardiol. 2014 Jul 26;6(7):517-30. doi: 10.4330/wjc.v6.i7.517. Review.

8.

A randomised controlled trial for the evaluation of risk for type 2 diabetes in hypertensive patients receiving thiazide diuretics: Diuretics In the Management of Essential hypertension (DIME) study.

Ueda S, Morimoto T, Ando S, Takishita S, Kawano Y, Shimamoto K, Ogihara T, Saruta T; DIME Investigators..

BMJ Open. 2014 Jul 16;4(7):e004576. doi: 10.1136/bmjopen-2013-004576.

9.

Thiazide diuretic prophylaxis for kidney stones and the risk of diabetes mellitus.

Singh P, Knoedler JJ, Krambeck AE, Lieske JC, Bergstralh EJ, Rule AD.

J Urol. 2014 Dec;192(6):1700-4. doi: 10.1016/j.juro.2014.06.078. Epub 2014 Jun 30.

10.

Misclassification in assessment of diabetogenic risk using electronic health records.

Winterstein AG, Kubilis P, Bird S, Cooper-DeHoff RM, Nichols GA, Delaney JA.

Pharmacoepidemiol Drug Saf. 2014 Aug;23(8):875-81. doi: 10.1002/pds.3656. Epub 2014 Jun 12.

11.

Potassium and glucose measures in older adults: the Cardiovascular Health Study.

Chatterjee R, Biggs ML, de Boer IH, Brancati FL, Svetkey LP, Barzilay J, Djoussé L, Ix JH, Kizer JR, Siscovick DS, Mozaffarian D, Edelman D, Mukamal KJ.

J Gerontol A Biol Sci Med Sci. 2015 Feb;70(2):255-61. doi: 10.1093/gerona/glu071. Epub 2014 Jun 3.

13.

Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study.

Shen L, Shah BR, Reyes EM, Thomas L, Wojdyla D, Diem P, Leiter LA, Charbonnel B, Mareev V, Horton ES, Haffner SM, Soska V, Holman R, Bethel MA, Schaper F, Sun JL, McMurray JJ, Califf RM, Krum H.

BMJ. 2013 Dec 9;347:f6745. doi: 10.1136/bmj.f6745. Erratum in: BMJ. 2014;348:f1339.

14.

A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide.

Segura J, Ruilope LM.

Vasc Health Risk Manag. 2013;9:521-8. doi: 10.2147/VHRM.S48291. Epub 2013 Sep 16. Review.

15.

Non-traditional risk factors are important contributors to the racial disparity in diabetes risk: the atherosclerosis risk in communities study.

Chatterjee R, Brancati FL, Shafi T, Edelman D, Pankow JS, Mosley TH, Selvin E, Yeh HC.

J Gen Intern Med. 2014 Feb;29(2):290-7. doi: 10.1007/s11606-013-2569-z. Epub 2013 Aug 14.

16.

Antihypertensive drug class interactions and risk for incident diabetes: a nested case-control study.

Cooper--DeHoff RM, Bird ST, Nichols GA, Delaney JA, Winterstein AG.

J Am Heart Assoc. 2013 Jun 10;2(3):e000125. doi: 10.1161/JAHA.113.000125.

17.

A retrospective longitudinal cohort study of antihypertensive drug use and new-onset diabetes in Taiwanese patients.

Huang CY, Ma T, Tien L, Hsieh YW, Lee SY, Chen HY, Jong GP.

Biomed Res Int. 2013;2013:287696. doi: 10.1155/2013/287696. Epub 2012 Dec 23.

18.

Lack of interaction of beta-cell-function-associated variants with hypertension on change in fasting glucose and diabetes risk: the Framingham Offspring Study.

de Miguel-Yanes JM, Porneala B, Pencina MJ, Fox CS, Florez JC, Siscovick DS, Dupuis J, Meigs JB.

J Hypertens. 2013 May;31(5):1001-9. doi: 10.1097/HJH.0b013e32835f5a83.

19.

The potential role of clinical pharmacy services in patients with cardiovascular diseases.

Talasaz AH.

J Tehran Heart Cent. 2012 Spring;7(2):41-6. Epub 2012 May 31.

20.

A new antihypertensive drug ameliorate insulin resistance.

Liu YX.

Acta Pharmacol Sin. 2012 Apr;33(4):429-30. doi: 10.1038/aps.2012.31. No abstract available.

Supplemental Content

Support Center